Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Xeris Pharmaceuticals and OHSU Conducting Artificial Pancreas Clinical Trial Using Xeris’ Novel Ready-to-Use Liquid Glucagon

pharmafocusasiaNovember 27, 2018

Tag: Xeris , OHSU , Liquid Glucagon , Diabetes

PharmaSources Customer Service